US FDA Still Fighting Problems With Pre-ANDA Meeting Requests

More meeting requests are being denied because the sponsor's pre-meeting package was incomplete, the agency said.

Helping Hand_169455167_1200.jpg
The FDA granted more pre-ANDA meetings for complex generics through the first nine months of FY 2019 than in all of FY 2018. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet